INS and type 2 diabetes mellitus: The combination of the need for hypersecretion of insulin to counteract the insulin resistance of T2D, the beta-cell dysfunction resulting from gluco- and lipotoxicity, amyloid toxicity, and disrupted microvasculature causes profound changes to the pulsatile nature of insulin release and the fine paracrine communication between beta-cells and other islet cell types.